¼¼°èÀÇ ÃµÀå°üÀý °íÁ¤ ÁÖ»ç ¹× RF ÀýÁ¦ ½ÃÀå
Sacroiliac Joint Fusion Injections and RF Ablation
»óǰÄÚµå : 1777532
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 364 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,195,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,585,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

õÀå°üÀý °íÁ¤ ÁÖ»ç ¹× RF ÀýÁ¦ ¼¼°è ½ÃÀåÀº 2030³â±îÁö 15¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 4¾ï 9,840¸¸ ´Þ·¯·Î ÃßÁ¤µÇ´Â õÀå°üÀý °íÁ¤ ÁÖ»ç ¹× RF ÀýÁ¦ ¼¼°è ½ÃÀåÀº ºÐ¼® ±â°£ 2024-2030³â¿¡ CAGR 20.1%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 15¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ º¯¼º¼±°ñ¿äÅëÁõÀº CAGR 22.0%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 9¾ï 8,930¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. õ°ñÆÄ±« ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 16.7%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 1¾ï 3,580¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 26.6%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ÃµÀå°üÀý °íÁ¤ ÁÖ»ç ¹× RF ÀýÁ¦ ½ÃÀåÀº 2024³â¿¡ 1¾ï 3,580¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 3¾ï 4,540¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 26.6%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 14.8%¿Í 18.3%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 16.1%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°è õÀå°üÀý °íÁ¤ÁÖ»ç ¹× RF ÀýÁ¦¼ú ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ Á¤¸®

õÀå°üÀý °íÁ¤ ÁÖ»ç ¹× RF ÀýÁ¦¼úÀ̶õ ¹«¾ùÀ̸ç, ¿Ö ºñ¼ö¼úÀû SI °üÀý ÅëÁõ °ü¸®ÀÇ ÇÙ½ÉÀÌ µÇ´Â°¡?

õÀå°üÀý(SI) ÁÖ»ç¿Í °íÁÖÆÄ(RF) ÀýÁ¦¼úÀº ¸¸¼º ¿äÅëÀÇ ÁÖ¿ä ¿øÀÎÀÎ SI °üÀý °ü·Ã ÅëÁõÀ» Áø´ÜÇÏ°í °ü¸®ÇÏ´Â µ¥ »ç¿ëµÇ´Â µÎ °¡Áö ÁÖ¿ä ºñ¼ö¼úÀû Ä¡·á¹ýÀÔ´Ï´Ù. SI°üÀý ÁÖ»ç´Â ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵峪 ¸¶ÃëÁ¦¸¦ °üÀý¿¡ Á÷Á¢ Åõ¿©ÇÏ¿© ¿°ÁõÀ» ¾ïÁ¦Çϰí ÀϽÃÀûÀÎ ÅëÁõÀ» ¿ÏÈ­ÇÕ´Ï´Ù. ¶ÇÇÑ, ÁÖ»ç ÈÄ ÅëÁõ ¿ÏÈ­°¡ È®ÀεǸé SI °üÀýÀÇ º´Å¸¦ È®ÀÎÇϱâ À§ÇØ Áø´ÜÀûÀ¸·Î »ç¿ëµË´Ï´Ù. ¹Ý¸é RF ÀýÁ¦¼úÀº °íÁÖÆÄ Àü·ù¸¦ ÀÌ¿ëÇØ SI °üÀý¿¡¼­ ÅëÁõ ½ÅÈ£¸¦ Àü´ÞÇÏ´Â °¨°¢½Å°æÀ» °¡¿­ÇØ ¹«·ÂÈ­½ÃŰ´Â °ÍÀ¸·Î Áֻ纸´Ù Àå±âÀûÀ¸·Î ÅëÁõÀ» ¿ÏÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù.

µÎ ½Ã¼ú ¸ðµÎ ¼ö¼úÀû õÀå°üÀý °íÁ¤¼úÀ» °í·ÁÇϱâ Àü¿¡ Áß¿äÇÑ Ä¡·á ´Ü°è°¡ µÉ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½Ã¼úÀº Á¤È®¼º°ú ¾ÈÀü¼ºÀ» À§ÇØ ¿µ»ó À¯µµ(Åõ½Ã ¶Ç´Â CT) ÇÏ¿¡ ¿Ü·¡¿¡¼­ ½ÃÇàÇÏ´Â °ÍÀÌ ÀϹÝÀûÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã¼úÀº ´çÀå ¼ö¼úÀ» ÇÒ ¼ö ¾ø´Â ȯÀÚ, ¼ö¼úÀ» ¹Ì·ç°í ½ÍÀº ȯÀÚ, ¼ö¼úÀ» º¹ÀâÇÏ°Ô ¸¸µå´Â ÇÕº´ÁõÀÌ Àִ ȯÀÚ¿¡°Ô ƯÈ÷ À¯¿ëÇÕ´Ï´Ù. SI °üÀýÅëÀÌ ÀÓ»óÀûÀ¸·Î Àνĵǰí Áø´ÜÀÇ Á¤È®µµ°¡ Çâ»óµÊ¿¡ µû¶ó, ÀÌ·¯ÇÑ ºñ¼ö¼úÀû ½Ã¼úÀº ´ÙÇÐÁ¦Àû ÅëÁõ °ü¸® Àü·«ÀÇ ÃÖÀü¼± ¼Ö·ç¼ÇÀ¸·Î ¼±È£µÇ°í ÀÖ½À´Ï´Ù.

±â¼ú Çõ½ÅÀº SI °üÀý ÁÖ»ç ¹× RF ÀýÁ¦¼úÀÇ È¿°ú¿Í ¾ÈÀü¼ºÀ» ¾î¶»°Ô Çâ»ó½Ã۰í Àִ°¡?

±â¼úÀÇ ¹ßÀüÀ¸·Î SI °üÀý ÁÖ»ç ¹× RF ÀýÁ¦¼úÀÇ ±â¼úÀÌ Á¤±³ÇØÁö¸é¼­ Á¤È®µµ, È¿°ú, ÅëÁõ ¿ÏÈ­ Áö¼Ó ½Ã°£ÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ÁÖ»ç´Â ÇöÀç ÃÊÀ½ÆÄ °¡À̵å¿Í ¿µ»ó À¶ÇÕ ±â¼úÀ» Ȱ¿ëÇÏ¿© º¸´Ù Á¤È®ÇÑ ¹Ù´Ã ¹èÄ¡°¡ °¡´ÉÇØÁ® ½Å°æ°ú Ç÷°ü ¼Õ»ó À§ÇèÀÌ °¨¼ÒÇϰí ÀÖ½À´Ï´Ù. Áö¼Ó¼º ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵峪 Ç÷¼ÒÆÇ dzºÎ Ç÷Àå(PRP), Áٱ⼼Æ÷ Á¦Á¦ µî »ý¹°ÇÐÀû ÁÖ»çÁ¦ÀÇ »ç¿ëÀº Ç׿°Áõ È¿°ú¸¦ Áö¼Ó½Ã۰í, ÀϽÃÀûÀÎ Áõ»ó ¾ïÁ¦¿¡ ±×Ä¡Áö ¾Ê°í °üÀýÀÇ Ä¡À¯¸¦ ÃËÁøÇϱâ À§ÇØ ¿¬±¸µÇ°í ÀÖ½À´Ï´Ù.

RF ÀýÁ¦¼úÀº Àü±Ø ¼³°è, ÀýÁ¦ ¾Ë°í¸®Áò ¹× ½Ã¼ú¿¡ ÀÖ¾î Å« Çõ½ÅÀÌ ÀϾ°í ÀÖ½À´Ï´Ù. ³Ã°¢ RF ÀýÁ¦¼úÀº ´õ Å« º´º¯ Å©±â¸¦ Á¦°øÇÏ°í º¯È­Çϱ⠽¬¿î ½Å°æ ÇØºÎÇÐÀû ±¸Á¶ÀÇ Ä¡·á¸¦ °³¼±ÇÏ´Â ¿ì¼öÇÑ ¹æ¹ýÀ¸·Î ºÎ»óÇϰí ÀÖÀ¸¸ç, ƯÈ÷ SI °üÀýÀÇ ½Å°æ Áö¹è¸¦ ´ã´çÇϴ õ°ñ ¿ÜÃø ºÐÁö(sacral lateral branch)¿¡ À¯¿ëÇÕ´Ï´Ù. ÆÞ½º RF ¹× ´ÙÁß º´º¯ RF ÇÁ·Îºê´Â ÅëÁõ ¿ÏÈ­ ±â°£À» ¿¬ÀåÇϸ鼭 Á¶Á÷ ¼Õ»óÀ» ÃÖ¼ÒÈ­Çϱâ À§ÇØ ¿¬±¸µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½Ç½Ã°£ ½Å°æ ¸ÅÇÎ ¹× ½Å°æ º¯Á¶ ±â¼úÀº ÀýÁ¦¼ú Áß ½Å°æ Ç¥ÀûÀÇ Æ¯À̼ºÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù.

ÀÏȸ¿ë ¸ê±Õ RF ŰƮ, ÀÚµ¿È­µÈ ÀýÁ¦ ÄܼÖ, Ä¡·á °èȹ ¹× Ä¡·á ÈÄ ÈÄ¼Ó Á¶Ä¡¸¦ °£¼ÒÈ­ÇÏ´Â ÅëÇÕ ÅëÁõ °ü¸® ¼ÒÇÁÆ®¿þ¾î Ç÷§ÆûÀÇ °³¹ß·Î ȯÀÚÀÇ ÆíÀǼº°ú ¾ÈÀü¼ºÀÌ ´õ¿í Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀº SI °üÀý ÁßÀç¼úÀÇ Àϰü¼º°ú ÀçÇö¼ºÀ» ³ô¿© ÅëÁõ Àü¹®ÀÇ¿Í ÁßÀçÀû ôÃß Àü¹®ÀÇ ¸ðµÎ¿¡°Ô ¸Å·ÂÀûÀ¸·Î ´Ù°¡°¥ ¼ö ÀÖµµ·Ï Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ö¿ä¸¦ ÁÖµµÇϴ ȯÀÚ±º°ú ÀÓ»ó »ç¿ë »ç·Ê´Â?

SI °üÀý ÁÖ»ç ¹× RF ÀýÁ¦¼ú¿¡ ´ëÇÑ ¼ö¿ä´Â ´Ù¾çÇÑ È¯ÀÚÃþ, ƯÈ÷ õÀå°üÀý ÅðÇ༺ Áúȯ, ÀÚ¼¼ ½ºÆ®·¹½º, ¿Ü»óÀ¸·Î ÀÎÇÑ ±â´É Àå¾Ö°¡ ¹ß»ýÇϱ⠽¬¿î 40¼¼ ÀÌ»óÀÇ ¼ºÀÎµé »çÀÌ¿¡¼­ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¿äÃß ¼ö¼ú, ƯÈ÷ ¿äÃß °íÁ¤¼úÀÇ º´·ÂÀÌ Àִ ȯÀÚ´Â ÀÎÁ¢ÇÑ SI °üÀýÀÇ ÅëÁõÀÌ ¹ß»ýÇÒ À§ÇèÀÌ ³ô±â ¶§¹®¿¡ Àç¼ö¼úÀ» °í·ÁÇϱâ Àü¿¡ ºñ¼ö¼úÀû ÁßÀç¿¡ ÀÇÁ¸ÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ¸¶Âù°¡Áö·Î Àδë ÀÌ¿ÏÀ̳ª »ý¿ªÇÐÀû ¿Ö°îÀ¸·Î ÀÎÇÑ »êÈÄ °ñ¹Ý ÅëÁõÀ» °æÇèÇÏ´Â ¿©¼ºµéµµ ÀÌ ¼ö¼ú¿¡ ¸¹ÀÌ ÀǷڵǰí ÀÖ½À´Ï´Ù.

ÀÌ·¯ÇÑ ÁßÀç´Â ºü¸¥ ȸº¹À» ¿øÇÏ°í ¼ö¼ú·Î ÀÎÇÑ ´Ù¿îŸÀÓÀ» ÇÇÇϰíÀÚ ÇÏ´Â ¿îµ¿¼±¼ö¿Í Ȱµ¿ÀûÀÎ »ç¶÷µé »çÀÌ¿¡¼­µµ Àα⸦ ¾ò°í ÀÖ½À´Ï´Ù. ¼ö¼ú À§ÇèÀÌ ³ôÀº °í·ÉÀÚ³ª ¿©·¯ ÇÕº´ÁõÀ» ¾Î°í Àִ ȯÀڵ鿡°Ô ÁÖ»ç¿Í RF ÀýÁ¦¼úÀº Àå±âÀûÀÎ °ü¸® ¼ö´ÜÀ¸·Î À¯¿ëÇÏ°Ô È°¿ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ºñ¸¸, °ñ°üÀý¿°, ÁÂ½Ä »ýȰ½À°üÀ¸·Î ÀÎÇÑ °üÀý ±â´É Àå¾ÖÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ SI °üÀýÅë Ä¡·á¸¦ ¹Þ´Â ȯÀÚÃþÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù.

´ëºÎºÐÀÇ ½ÅÈï±¹ ½ÃÀå¿¡¼­ º¸Çè Àû¿ë°ú Áõ°Å ±â¹Ý Ä¡·á °æ·Î ¹× º¸Çè Àû¿ëÀ¸·Î µÞ¹ÞħµÇ´Â ÀÇ·á ½Ã½ºÅÛÀº SI °üÀý ÁÖ»ç ¹× ÀýÁ¦¼úÀ» ¸¸¼º ÅëÁõ °ü¸® ÇÁ·Î±×·¥¿¡ Æ÷ÇÔ½ÃŰ´Â Ãß¼¼ÀÔ´Ï´Ù. ôÃß Àü¹® Ŭ¸®´Ð°ú ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ´Â ÃÖ¼Òħ½À¼º, ³·Àº ÇÕº´Áõ ¹ß»ý·ü, ³ôÀº ºñ¿ë È¿°ú¼ºÀ¸·Î ÀÎÇØ ÀÌ·¯ÇÑ Ä¡·áÀÇ °ÅÁ¡ÀÌ µÇ°í ÀÖ½À´Ï´Ù.

õÀå°üÀý °íÁ¤ ÁÖ»ç ¹× RF ÀýÁ¦¼ú ¼¼°è ½ÃÀå ¼ºÀå ¿øµ¿·ÂÀº ¹«¾ùÀΰ¡?

¼¼°è õÀå°üÀý °íÁ¤ ÁÖ»ç ¹× RF ÀýÁ¦¼ú ½ÃÀåÀÇ ¼ºÀåÀº SI °üÀý ±â´É Àå¾ÖÀÇ À¯º´·ü Áõ°¡, ÀÓ»óÀû ÀÎ½Ä ¹× Áø´Ü Á¤È®µµ Çâ»ó, ºñ¼ö¼úÀû ÅëÁõ °ü¸®¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÃÖ¼Òħ½ÀÀû ÁßÀçÀû ÅëÁõ Ä¡·áÀÇ È®´ë´Â ¿Ü·¡ ȯÀÚµéÀÇ ¼±È£¿Í ÇÔ²² ¿Ü·¡¿¡¼­ À§Çèµµ°¡ ³·Àº ½Ã¼úÀ» ¼±È£Çϴ ȯÀÚµéÀÇ ¼±È£¿Í ¸Â¹°·Á ½ÃÀå µµÀÔÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù.

¿µ»óÀ¯µµÁßÀç¼ú, ½Å°æ¼ÒÀ۽ýºÅÛ, Àç»ýÁÖ»çÁ¦ µîÀÇ ±â¼ú¹ßÀüÀ¸·Î Ä¡·á¼ºÀûÀÌ Çâ»óµÇ°í »ç¿ë»ç·Ê°¡ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç¿¡¼­´Â °ø°ø ¹× ¹Î°£ ÀÇ·á ½Ã½ºÅÛ ¸ðµÎ¿¡¼­ º¸´Ù Æø³ÐÀº »ç¿ëÀ» ÃËÁøÇϱâ À§ÇØ »óȯÁ¦µµÀÇ Æ²ÀÌ ¸¶·ÃµÇ°í ÀÖ½À´Ï´Ù. SI °üÀý Ä¡·á°¡ ¿äÅëÀÇ ´ÙÇÐÁ¦Àû Ä¡·á ¸ðµ¨¿¡ ÅëÇյǰí, °¡Ä¡ ±â¹Ý ÀÇ·á ¹× ¿ÀÇÇ¿ÀÀ̵å Àý¾à Àü·«À¸·ÎÀÇ ÀüȯÀº ÁÖ»ç ¹× RF ÀýÁ¦¼ú¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ôÃß ¹× ÅëÁõ Àü¹®°¡µéÀÌ ÃµÀå°üÀýÀ» ¸¸¼º ÅëÁõÀÇ Áß¿äÇÑ ¿øÀÎÀ¸·Î ÀνÄÇÏ°Ô µÇ¸é¼­, Ç¥ÀûÈ­µÈ ¿µ»ó À¯µµ ÁßÀçÀÇ ¿ªÇÒÀº °è¼Ó È®´ëµÇ°í ÀÖ½À´Ï´Ù. Áö¼ÓÀûÀÎ ±â¼ú Çõ½Å, ÃÖ¼Òħ½ÀÀû ¼Ö·ç¼Ç¿¡ ´ëÇÑ È¯ÀÚ ¼ö¿ä Áõ°¡, ÀÓ»ó Àû¿ë È®´ë¿¡ µû¶ó SI °üÀýÁÖ»ç ¹× RF ÀýÁ¦¼ú ½ÃÀåÀº Àü ¼¼°èÀûÀ¸·Î Áö¼ÓÀûÀ¸·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÎ¹®

ÀûÀÀÁõ(ÅðÇ༺ õÀå°üÀý¿°, õ°ñ ÆÄ±«, ¿Ü»ó), À¯Çü(Áø´Ü, Ä¡·á), ÃÖÁ¾»ç¿ëÀÚ(º´¿ø, ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ, ±âŸ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM ¹× ¾÷°èº° SLM Äõ¸®¸¦ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Sacroiliac Joint Fusion Injections and RF Ablation Market to Reach US$1.5 Billion by 2030

The global market for Sacroiliac Joint Fusion Injections and RF Ablation estimated at US$498.4 Million in the year 2024, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 20.1% over the analysis period 2024-2030. Degenerative Sacroilitis, one of the segments analyzed in the report, is expected to record a 22.0% CAGR and reach US$989.3 Million by the end of the analysis period. Growth in the Sacral Disruption segment is estimated at 16.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$135.8 Million While China is Forecast to Grow at 26.6% CAGR

The Sacroiliac Joint Fusion Injections and RF Ablation market in the U.S. is estimated at US$135.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$345.4 Million by the year 2030 trailing a CAGR of 26.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 14.8% and 18.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 16.1% CAGR.

Global Sacroiliac Joint Fusion Injections and RF Ablation Market - Key Trends & Drivers Summarized

What Are Sacroiliac Joint Fusion Injections and RF Ablation, and Why Are They Key to Non-Surgical SI Joint Pain Management?

Sacroiliac (SI) joint injections and radiofrequency (RF) ablation are two leading non-surgical interventions used for the diagnosis and management of SI joint-related pain, a significant contributor to chronic low back pain. SI joint injections involve the targeted delivery of corticosteroids and/or anesthetics directly into the joint to reduce inflammation and provide temporary pain relief. They are also used diagnostically to confirm SI joint pathology when pain relief is observed following the injection. In contrast, RF ablation uses high-frequency electrical currents to heat and disable the sensory nerves transmitting pain signals from the SI joint, offering longer-lasting relief than injections.

Both techniques serve as critical therapeutic steps before considering surgical sacroiliac joint fusion. They are commonly performed in outpatient settings under image guidance (fluoroscopy or CT) for precision and safety. These interventions are particularly valuable for patients who are not immediate surgical candidates, wish to delay surgery, or have comorbidities that complicate operative procedures. As SI joint pain becomes more clinically recognized and diagnostic accuracy improves, these non-surgical procedures are gaining traction as frontline solutions in multidisciplinary pain management strategies.

How Are Innovations Enhancing the Effectiveness and Safety of SI Joint Injections and RF Ablation?

Technological advancements are refining both SI joint injections and RF ablation techniques, improving their precision, efficacy, and duration of pain relief. Injections now leverage ultrasound-guided and image-fusion techniques, allowing for more accurate needle placement and reduced risk of nerve or vascular injury. The use of long-acting corticosteroids and biologic injectables-such as platelet-rich plasma (PRP) and stem cell formulations-is being explored to prolong anti-inflammatory effects and promote joint healing beyond temporary symptom suppression.

In RF ablation, significant innovation is occurring in electrode design, ablation algorithms, and procedural techniques. Cooled RF ablation is emerging as a superior method, offering larger lesion sizes and improved treatment of variable nerve anatomy, which is especially beneficial for the sacral lateral branches responsible for SI joint innervation. Pulsed RF and multi-lesion RF probes are also being investigated to minimize tissue damage while extending the duration of pain relief. Additionally, real-time nerve mapping and neuromodulation technologies are enhancing the specificity of nerve targeting during ablation procedures.

Patient comfort and safety are being further improved with the development of disposable, sterile RF kits, automated ablation consoles, and integrated pain management software platforms that streamline treatment planning and post-procedural follow-up. These innovations are making SI joint interventions more consistent, reproducible, and appealing to both pain specialists and interventional spine physicians.

Which Patient Populations and Clinical Use Cases Are Driving Market Demand?

The demand for SI joint injections and RF ablation is increasing among diverse patient demographics, particularly among adults aged 40 and above who are more prone to sacroiliac degeneration, postural stress, or trauma-induced dysfunction. Patients with a history of lumbar spine surgery-especially lumbar fusion-are at elevated risk of developing adjacent SI joint pain and often turn to non-surgical interventions before considering revision surgery. Similarly, women experiencing postpartum pelvic pain due to ligamentous laxity or biomechanical strain are increasingly being referred for these procedures.

These interventions are also gaining popularity among athletes and active individuals who seek quicker recovery and want to avoid surgical downtime. In elderly patients or those with multiple comorbidities, where surgery poses higher risks, injections and RF ablation serve as valuable long-term management tools. Moreover, the increasing prevalence of obesity, osteoarthritis, and sedentary lifestyle-induced joint dysfunction is broadening the patient base for SI joint pain treatment.

Healthcare systems are increasingly integrating SI joint injections and ablation into chronic pain management programs, supported by evidence-based care pathways and insurance coverage in most developed markets. Multidisciplinary spine clinics and ambulatory surgery centers are becoming hubs for these procedures, given their minimally invasive nature, low complication rates, and strong cost-effectiveness profile.

What Is Driving the Growth of the Global Sacroiliac Joint Fusion Injections and RF Ablation Market?

The growth in the global sacroiliac joint fusion injections and RF ablation market is driven by several factors, including rising prevalence of SI joint dysfunction, increased clinical awareness and diagnostic accuracy, and growing demand for non-surgical pain management alternatives. The expansion of minimally invasive interventional pain practices, coupled with patient preference for outpatient, low-risk procedures, is accelerating market adoption.

Technological advancements in image-guided intervention, nerve ablation systems, and regenerative injectables are enhancing treatment outcomes and broadening use cases. Additionally, supportive reimbursement frameworks in North America, Europe, and increasingly in Asia-Pacific are encouraging wider use in both public and private healthcare systems. The integration of SI joint procedures into multidisciplinary care models for low back pain, along with a shift toward value-based healthcare and opioid-sparing strategies, is further boosting the demand for injections and RF ablation.

As spine and pain specialists increasingly recognize the sacroiliac joint as a significant source of chronic pain, the role of targeted, image-guided interventions continues to grow. With ongoing innovation, rising patient demand for minimally invasive solutions, and expanding clinical application, the SI joint injections and RF ablation market is poised for sustained global expansion in the years ahead.

SCOPE OF STUDY:

The report analyzes the Sacroiliac Joint Fusion Injections and RF Ablation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Indication (Degenerative Sacroilitis, Sacral Disruption, Trauma); Type (Diagnosis, Treatment); End-Use (Hospitals, Ambulatory Surgery Centers, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â